首页> 美国卫生研究院文献>Veterinary Research >Anchoring tick salivary anti-complement proteins IRAC I and IRAC II to membrane increases their immunogenicity
【2h】

Anchoring tick salivary anti-complement proteins IRAC I and IRAC II to membrane increases their immunogenicity

机译:将tick唾液抗补体蛋白IRAC I和IRAC II锚定在膜上可增加其免疫原性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Tick salivary proteins are promising targets for the development of anti-tick vaccines. Recently, we described two paralogous anti-complement proteins, called Ixodes ricinus anti-complement (IRAC) proteins I and II, that are co-expressed in tick I. ricinus salivary glands. However, our previous attempts to immunize rabbits against IRAC via infection with recombinant Bovine herpesvirus 4 (BoHV-4) vectors invariably failed although both recombinants expressed high levels of functional IRAC proteins in vitro. As IRAC are soluble monovalent antigens, one of the possible explanations is that monovalent ligation of the B-cell receptor induces receptor activation but fails to promote antigen presentation, a phenomenon that is thought to induce a state of B-cell tolerance. In the present study, we tried to increase IRAC immunogenicity by expressing them as oligovalent antigens. To this end, IRAC were fused to membrane anchors and BoHV-4 vectors expressing these recombinant forms were produced. The immunization potentials of recombinant viruses expressing either secreted or transmembrane IRAC proteins were then compared. While the former did not induce a detectable immune response against IRAC, the latter led to high titres of anti-IRAC antibodies that only marginally affected tick blood feeding. All together, the data presented in this study demonstrate that the immunogenicity of a soluble antigen can be greatly improved by anchoring it in membrane.
机译:壁虱唾液蛋白是抗壁虱疫苗开发的有希望的目标。最近,我们描述了在para I. ricinus唾液腺中共表达的两种旁系抗补体蛋白,称为Ixodes ricinus抗补体(IRAC)蛋白I和II。然而,我们先前通过重组牛疱疹病毒4(BoHV-4)载体感染而免疫兔抗IRAC的尝试始终失败,尽管两个重组体均在体外表达了高水平的功能性IRAC蛋白。由于IRAC是可溶的单价抗原,可能的解释之一是B细胞受体的单价连接会诱导受体激活,但不能促进抗原呈递,这种现象被认为会诱导B细胞耐受状态。在本研究中,我们试图通过将其表达为寡价抗原来提高IRAC的免疫原性。为此,将IRAC与膜锚融合,并产生表达这些重组形式的BoHV-4载体。然后比较表达分泌型或跨膜IRAC蛋白的重组病毒的免疫潜力。尽管前者未诱导出针对IRAC的可检测的免疫反应,但后者导致了高滴度的抗IRAC抗体,这些抗体仅微幅影响了feeding血的摄食。总之,本研究中提供的数据表明,通过将可溶性抗原锚定在膜上可以大大提高其免疫原性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号